IMRX logo

IMRX
Immuneering Corp

2,956
Mkt Cap
$351.91M
Volume
1.52M
52W High
$10.08
52W Low
$1.10
PE Ratio
-3.95
IMRX Fundamentals
Price
$5.05
Prev Close
$5.45
Open
$5.47
50D MA
$5.21
Beta
1.38
Avg. Volume
800,103.72
EPS (Annual)
-$1.27
P/B
1.61
Rev/Employee
$0.00
$120.59
Loading...
Loading...
News
all
press releases
Immuneering (IMRX) to Release Earnings on Thursday
Immuneering (NASDAQ:IMRX) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 19. (View Earnings Report at...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Immuneering's (IMRX) "Buy" Rating Reiterated at Needham & Company LLC
Needham & Company LLC reissued a "buy" rating and issued a $11.00 price objective on shares of Immuneering in a research note on Monday...
MarketBeat·5d ago
News Placeholder
Immuneering (NASDAQ:IMRX) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Immuneering from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·7d ago
News Placeholder
Monashee Investment Management LLC Makes New Investment in Immuneering Corporation $IMRX
Monashee Investment Management LLC acquired a new stake in Immuneering Corporation (NASDAQ:IMRX - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and...
MarketBeat·13d ago
News Placeholder
Immuneering Touts 64% 12-Month Survival for Atebimetinib in Pancreatic Cancer, Eyes Phase 3
Immuneering (NASDAQ:IMRX) Chief Executive Officer and co-founder Ben Zeskind told attendees at Oppenheimer's 36th Annual Healthcare Life Sciences Conference that the company is focused on improving...
MarketBeat·14d ago
News Placeholder
Immuneering Corporation (NASDAQ:IMRX) Given Average Rating of "Moderate Buy" by Brokerages
Immuneering Corporation (NASDAQ:IMRX - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven analysts that are covering the stock, MarketBeat reports. One...
MarketBeat·16d ago
News Placeholder
Sanofi Invests $18.96 Million in Immuneering Corporation $IMRX
Sanofi bought a new stake in shares of Immuneering Corporation (NASDAQ:IMRX - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The...
MarketBeat·1mo ago
News Placeholder
Immuneering Corporation (NASDAQ:IMRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Immuneering Corporation (NASDAQ:IMRX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the firm, Marketbeat reports...
MarketBeat·1mo ago
News Placeholder
Immuneering (NASDAQ:IMRX) Insider Purchases $24,990.00 in Stock
Immuneering Corporation (NASDAQ:IMRX - Get Free Report) insider Harold Eugene Brakewood purchased 5,250 shares of the business's stock in a transaction dated Friday, January 16th. The shares were...
MarketBeat·2mo ago
News Placeholder
Immuneering (NASDAQ:IMRX) Insider Harold Eugene Brakewood Purchases 5,250 Shares of Stock
Immuneering Corporation (NASDAQ:IMRX - Get Free Report) insider Harold Eugene Brakewood purchased 5,250 shares of Immuneering stock in a transaction dated Friday, January 16th. The shares were...
MarketBeat·2mo ago
<
1
2
...
>

Latest IMRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.